All Stories

  1. Human suicide, clinical treatment overview
  2. Sialic Acids and Cancer: Pathophysiological Association between Metastatic Progress and Treatment
  3. Anticancer Drug Development, Pharmaceutical Progress
  4. Type 2 Diabetes Treatments in Countries of Different Economic Status
  5. Human suicide, biomedical knowledge and therapeutic advances
  6. Human Suicide, an Overview of Management Strategies
  7. COVID-19 Research, Public Health and Biomedical Basis
  8. Human Suicide, Management Landscape
  9. Anticancer Drug Development: Evaluative Architecture
  10. COVID-19 Study: A New Principle Discovery
  11. COVID-19 Study, Diagnostic and Therapeutic Transition
  12. Antimetastatic Drug, Pharmacologic Challenge and Opportunity
  13. Nursery services advances, global campaign
  14. Different approaches to bone transplantation surgery
  15. Bone Metastasis Diagnosis, Blood Biomarker Detections
  16. Anti-metastatic drug development, overview and perspectives
  17. Educational Perspectives for Nursery
  18. Is Tau Molecule Regarded as a Risk Factor for Human Suicide?
  19. Drug Sensitivity Testing for Cancer Therapy, Technique Analysis and Trends
  20. Pulmonary nodules, is there any pathogenesis evidence?
  21. HIV/AIDS Curability Study, Different Approaches and Drug Combination
  22. Pulmonary nodules, surgery or other medication
  23. Bone Metastasis and Circulation Biomarkers Profiling Towards Personalized Cancer Medicine
  24. Pulmonary Nodules, Surgery or Other Medication
  25. Anti-Metastatic Drug Developments, Utility of More Animal Models
  26. Several approaches for anticancer drug development progress
  27. Drug Sensitivity Testing for Cancer Therapy, Key Areas
  28. COVID-19 infection for metabolic abnormal human beings
  29. Fundamental knowledge for nurses 
  30. Nursery promotion, education and system updating
  31. Cancer Bone Metastasis, Diagnostic Insights and Drug Selection
  32. Acupuncture for Bone Disease Treatments, Modern Approaches
  33. Cancer Bone Metastasis, Experimental Study
  34. Neuropsychiatric Approaches for Human Suicide Prediction and Management
  35. Osteoporosis Targeting, Possible Breakthroughs
  36. Neuropsychiatric insights for human suicide
  37. Bone Cancer and Metastasis Trials, Drug Treatment
  38. Neurobiology for human suicide
  39. Bone Disease Treatment Study, Major Pathways
  40. Pathology Study for Human Suicide
  41. Nursery activity and quality, chemistry between doctors and nurses
  42. Nursery education, narrow-range or wide-range
  43. Anticancer drug development, challenge and dilemma
  44. Life Origin on Earth, Knowledge Development
  45. HIV/AIDS treatment, therapeutic strategy break throughs
  46. Nursery education for diabetes
  47. Suicide Risks and Prevention, Neuropathogenic Study
  48. Medical Treatments for Chronic or Aggressive Diseases, Palliative Therapy and Nursery
  49. General information for nursery
  50. Historical analysis of suicide
  51. Drug sensitivity testing, a unique drug selection strategy
  52. Natural drug cancer treatments, strategies from herbal medicine to chemical or biological drugs
  53. Medical treatments for incurable diseases, palliative therapy
  54. Life Origin on Earth, Biochemical Approaches
  55. Nursery training, from technique details in schools into medical knowledge education in nursery career
  56. Herbal medicine in new era
  57. Nursery service, quality promotion
  58. Anti-Metastatic Drug Developments, Biomedical Mechanisms and Therapeutic Categorization
  59. Patient’s care and nursery in different diseases
  60. New HIV/AIDS Therapeutics
  61. Nursery Service in Modern Days
  62. Nursery Education, Capability and Service Promotion
  63. Nursery Science and Conventions
  64. Cancer Bioinformatics in Cancer Therapy
  65. Individualized Cancer Therapy
  66. Human Suicide Risk and Treatment Study
  67. Type 2 Diabetes Treatment and Drug Development Study
  68. Hypotheses for Life Origin on Earth, Comparison and Validation
  69. Type 2 Diabetes Study, Introduction and Perspective
  70. Type 2 Diabetes Mellitus Study, A Process of Enigma unraveling
  71. Anthocyanins and its biological & therapeutic characters
  72. Diabetes Prevention and Treatments, a Specific Topic for Modern Medicines
  73. A Critical Appraisal of Different Food Safety and Quality Management Tools to Accomplish Food Safety
  74. Pathology and treatments of obesity
  75. Obesity, Risks and Managements
  76. Keep up the pace of drug development evolution and expenditure
  77. An Overview of Obesity
  78. General Topics in the Field of Personalized Cancer Therapy
  79. Human Suicide Risk Study and Treatment: A Mathematical Approach
  80. Anti-Metastatic Drug Developments: Work Out towards New Direction
  81. Diabetes Mellitus and Male Aging: Pharmacotherapeutics and Clinical Implications
  82. Drug Combination in Clinical Cancer Treatments
  83. General outlook for individualized cancer therapy
  84. Ebola origin and treatment
  85. Different Disciplines in the Field of Suicide Study
  86. Cancer Bioinformatics for Updating Anticancer Drug Developments and Personalized Therapeutics
  87. HAART in HIV/AIDS Treatments
  88. Anticancer Drug Development, System Updating and Global Participations
  89. Life Origin on Earth, What is the Right Answer?
  90. Human suicide study, major disciplines and treatment outcomes
  91. Anticancer drug development
  92. HIV in Human Genomes and Therapeutics
  93. HIV Biotherapy and Natural Chemotherapeutic Agents
  94. Anticancer Drug Combinations, How Far We can Go Through?
  95. Antimetastatic therapy at aberrant sialylation in cancer cells, a potential hotspot
  96. Life Origin on Earth, Insights among Different Arguments
  97. Genetics in Suicide Treatments, Modern Diagnosis Establishments
  98. Diabetes Preventions and Treatments, a Specific Topic for Modern Medicines
  99. Cancer metastasis treatment, a key drawbacks
  100. The suicide treatment, a new model
  101. HIV Vaccine for Prevention and Cure, A Mission Possible
  102. Zika Therapy
  103. HIV vaccine
  104. Discover Natural Chemical Drugs in Modern Medicines
  105. Mathematics in biomedical science
  106. The origin of HIV
  107. Human suicide study
  108. Mathematics or Physics-Majored Students on the Biomedical Fields, Insiders or Outsiders?
  109. Pharmacogenetics of Cancer Therapy
  110. Anticancer Drug Sensitivity Testing
  111. New Perspectives of HIV/AIDS Therapy Study
  112. Antidepressant treatment study
  113. Clinical neoplasm metastasis treatments according to patient's personal conditions.
  114. Assistant cancer treatments in the clinic
  115. Drug sensitivity testing in clinical cancer treatments
  116. Anticancer drug combination in the clinic
  117. Anticancer drug pharmacogenomics in cancer chemotherapy
  118. Cost-effectiveness for personalized cancer therapy
  119. Conclusion
  120. Introduction
  121. Discussion
  122. Cancer biomarker/bioinformatics detection in clinical cancer treatments
  123. Anti-diabetic treatments
  124. Anticancer Drug Combinational Study
  125. The Origins of HIV
  126. Plasma Fibrinogen Concentrations in Patients with Solid Tumors and Therapeutic Improvements by Combining Anticoagulants or Fibrinolytical Agents
  127. Anticancer Drug Combinations, A Big Momentum is Needed
  128. Anticancer Drug Development, a Matter of Money or a Matter of Idea?
  129. Future Perspectives for Controlling Ebola Epidemics
  130. Ebola Origin and Therapies
  131. Cancer Bioinformatics, its Impacts on Cancer Therapy
  132. Copyright
  133. List of figures and tables
  134. Anti-diabetic treatments, patho-therapeutic relation
  135. Origin of Ebola, hypothesis
  136. Personalized Cancer Therapy: A Perspective
  137. Rethink Of Diabetes Treatment and Drug Development
  138. Pharmacogenomics in human suicide prediction and treatments
  139. Cancer metastasis treatment study and drug developments
  140. Challenge for HIV/AIDS therapy
  141. Cost-effectiveness Considerations of Individualized Cancer Chemotherapy
  142. Drug Combinations in Cancer Treatments
  143. New Insights into Individualized Antimetastatic Therapy
  144. Anticancer drugs on serum sialic acid level in mice bearing LLC
  145. Drug Combinations in Cancer Treatments
  146. Genetics in Neural Toxicity of Drugs
  147. Avian flu, pathogenesis and therapeutic study
  148. First Genetic Information Replication in Life Origin on Earth
  149. Origins of Life, A New Cooperative Model
  150. Cancer Metastases and Clinical Therapies
  151. Origins of Life, RNA world or alternative RNA world
  152. Development of Antimetastatic Drugs by Targeting Tumor Sialic Acids
  153. Individualized Cancer Chemotherapy by Detecting Cancer Biomarkers
  154. Antimetastatic Therapies according to Metastatic Cascade
  155. Genetics in antidepressant-induced suicide
  156. Pathology of Drug-induced mania & suicide
  157. Influenza treatment
  158. High Active Anti-retroviral Therapy for HIV/AIDS, Progresses and Drawback
  159. Individualized cancer chemotherapy
  160. High Active Antiretroviral Therapy for HIV/AIDS-Early Intervention or Later Intervention?
  161. The Hypotheses for the Pathogeny of Drug-Induced Mania and Suicide
  162. The Relationship between Tumor Sialic Acids and Neoplasm Metastasis and as a Drug Target
  163. Genomic study of antidepressant-induced suicide
  164. Aberrant sialylation in tumor cells
  165. Anti-mobility of Bisdioxopiperanes against human mammary tumors
  166. Antimetastatic activity and mechanisms of action of Bisdioxopiperazine compounds
  167. Neural toxicity of drugs
  168. Anticancer activity and mechanisms of Bisdioxopiperazines
  169. Different Spontaneous Pulmonary Metastasis Inhibitions against Lewis Lung Carcinoma in Mice by Bisdioxopiperazine Compounds of Different Treatment Schedules
  170. 14C-probimane in the mice bearing LLC
  171. Unsatisfactory design of human AIDS genome research
  172. Antidepressant in Cancer Treatment
  173. AIDS and human genome studies, from a hypothesis to systematic approaches
  174. Antidepressants in Human suicide
  175. Mathematical model in therapeutic risk prediction
  176. Fibrinogen in neoplasm metastasis
  177. Sequencing the whole genome of infected human cells obtained from diseased patients – a proposed strategy for understanding and overcoming AIDS or other deadest virus-infected diseases
  178. Relationship Between Blood Fibrinogen Concentration and Pathological Features of Cancer Patients: A 139-case Clinical Study
  179. Medicinal Chemistry of Probimane and MST-16: Comparison of Anticancer Effects Between Bisdioxopiperazines
  180. Individualized cancer chemotheray
  181. Anti-proliferative and chromosome segregation by probimane and MST-16
  182. Effect of Anti-Cancer Drugs on the Binding of 125I-Fibrinogen to Two Leukaemia Cell Lines In Vitro
  183. Antitumor effects of two bisdioxopiperazines against two experimental lung cancer models in vivo
  184. Inhibition of probimane on lipid peroxidation of rabbit and human erythrocytes
  185. Aberration of sialylation in neoplasm metastasis and possible therapeutics
  186. Effects of Cancer Chemotherapy on the Blood Fibrinogen Concentrations of Cancer Patients
  187. Effect of magnetized water on the mice given high doses of antineoplastic drugs
  188. Inhibition of probimane on lipoperoxidation of human red cells in vitro
  189. Enzyme dynamic study on calmodulin Ca++-Mg++-ATPase system of red blood cells inhibited by α-anordrin and probimane
  190. Journal of Clinical and Medical Reviews